Inhibition of protein kinase C in diabetic nephropathy - Where do we stand

Nephrology Dialysis Transplantation

Volumn 24, Issue 7, 2009, Pages 2021-2023

  Menne, Jan ^a   Meier, Matthias ^a   Park, Joon Keun ^a   Haller, Hermann ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Diabetic nephropathy; Protein kinase C

Indexed keywords

PLACEBO; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C INHIBITOR; RUBOXISTAURIN; VASCULOTROPIN;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIABETIC NEPHROPATHY; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEINURIA;

ANIMALS; DIABETIC NEPHROPATHIES; HUMANS; PROTEIN KINASE C;

EID: 67651099018     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp150     Document Type: Note

References (30)

1. Lee T-S, Saltsman KA, Ohashi H et al. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci 1989; 86: 5141-5145
2. Craven PA, DeRubertis FR. Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. J Clin Invest 1989; 83: 1667-1675
3. 2+ signaling via NADPH oxidase and diacylglycerol-sensitive protein kinase C isozymes in mesangial cells. JBiolChem 2003; 278: 33951-33962
4. Noh H, King GL. The role of protein kinase C activation in diabetic nephropathy. Kidney Int Suppl 2007 106: S49-S53
5. Dempsey EC, Newton AC, Mochly-Rosen D et al. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 2000; 279: L429-L438
6. Gould CM, Newton AC. The life and death of protein kinase C. Curr Drug Targets 2008; 9: 614-625
7. Ohno S, Nishizuka Y. Protein kinase C isotypes and their specific functions: prologue. J Biochem 2002; 132: 509-511
8. Inoguchi T, Battan R, Handler E et al. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 1992; 89: 11059-11063
9. Meier M, Menne J, Haller H. Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice. Diabetologia 2009 Feb 24. [Epub ahead of print]
10. Menne J, Park J-K, Boehne M et al. Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice. Diabetes 2004; 53: 2101-2109
11. Menne J, Meier M, Park JK et al. Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in vivo. Kidney Int 2006; 70: 1456-1462
12. Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS et al. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 2002; 51: 3090-3094
13. Vriese ASD, Tilton RG, Elger M et al. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 2001; 12: 993-1000
14. Ohshiro Y, Ma RC, Yasuda Y et al. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase C beta-null mice. Diabetes 2006; 55: 3112-3120
15. Meier M, Park J, Overheu D et al. Deletion of protein kinase C-ß isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model. Diabetes 2007; 56: 346-354
16. Thallas-Bonke V, Thorpe SR, Coughlan MT et al. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes 2008; 57: 460-469
17. Thallas-Bonke V, Lindschau C, Rizkalla B et al. Attenuation of extra-cellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway. Diabetes 2004; 53: 2921-2930
18. Braz JC, Gregory K, Pathak A et al. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med 2004; 10: 248-254
19. Konopatskaya O, Gilio K, Harper MT et al. PKCalpha regulates platelet granule secretion and thrombus formation in mice. J Clin Invest 2009; 119: 399-407
20. Ishii H, Jirousek MR, Koya D et al. Amelioration of vascular dys-functions in diabetic rats by an oral PKC beta inhibitor. Science 1996; 272: 728-731
21. Tuttle KR, Bakris GL, Toto RD et al. The effect of ruboxistaurin on nephropathy in type 2 diabetes. Diabetes Care 2005; 28: 2686-2690
22. Tuttle KR, McGill JB, Haney DJ et al. and P.-D. for the PKC-DRS, and PKC-DRS 2 Study Groups. Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease. Clin J Am Soc Nephrol 2007; 2: 631-636
23. Bakris GL. Protein kinase C-beta inhibition: a promise not yet fulfilled. Clin J Am Soc Nephrol 2007; 2: 619-620
24. Gilbert RE, Kim SA, Tuttle KR et al. Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes. Diabetes Care 2007; 30: 995-996
25. Koya D, Jirousek MR, Lin Y-W et al. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 1997; 100: 115-126
26. Koya D, Haneda M, Nakagawa H et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. Faseb J 2000; 14: 439-447
27. Kelly DJ, Zhang Y, Hepper C et al. Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension. Diabetes 2003; 52: 512-518
28. Coussens L, Parker PJ, Rhee L et al. Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways. Science 1986; 233: 859-866
29. Meier M, Menne J, Park J-K et al. Deletion of protein kinase C-varepsilon signaling pathway induces glomerulosclerosis and tubulointerstitial fibrosis in vivo. J Am Soc Nephrol 2007; 18: 1190-1198
30. Tang S, Xiao V, Wei L, Protein kinase C isozymes and their selectivity towards ruboxistaurin. Proteins 2008; 72: 447-460